Stay updated on Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter updates show a new footer revision 'Revision: v3.3.3' added and the previous 'Revision: v3.3.2' entry along with the 'HHS Vulnerability Disclosure' link removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page history shows the addition of Revision: v3.3.2 and removal of Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page history now shows Revision: v3.3.1 in place of Revision: v3.2.0 as part of a system update.SummaryDifference0.0%

- Check49 days agoChange DetectedThe lapse-in-funding notice about potential data delays and operating status has been removed from the page.SummaryDifference0.3%

- Check63 days agoChange DetectedThe images reflect added version entries in the Record History, with updated dates and statuses, while the main study data remains unchanged.SummaryDifference0.1%

- Check92 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference8%

Stay in the know with updates to Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.